Howard Horn, Chief Financial Officer at Ultragenyx Pharmaceutical, sold RARE on Aug 3, 2026
Data as of Oct 16
▼ SELL$117K4,696 shares at $24.92Howard Horn Chief Financial OfficerRARE Ultragenyx Pharmaceutical Inc.
- Traded
- Aug 3, 2026
- Disclosed
- Aug 4, 2026
- Filed
- 1 day after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
RARE since disclosure
−43.7%
after the sale
Similar stocks (XLV) since disclosure
+9.0%
XLV — its sector index fund
Change in closing price from Aug 4, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.